BGT-DTDS

N/A

Report date: 2024/09/06 16:16:33

Base Information

Drug NameBGT-DTDS
Drug Alias Nameadeno-associated viral vector serotype 2 containing the human SLC6A3 geneAAV-2 containing the human SLC6A3 geneBGT-DTDS
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionDopamine transporter agonists
TargetsDopamine transporter
Therapy Area/IndicationsDopamine transporter deficiency syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBloomsbury Genetic Therapies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBloomsbury Genetic Therapies Ltd
Inactive CompaniesN/A
Active IndicationsDopamine transporter deficiency syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A